The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.

The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.
复制标题

DOI:
10.1021/jm2008985
复制
发表时间:
2011-10-13
影响因子:
7.3
通讯作者:
Thompson, Paul R.
Thompson, Paul R.
中科院分区:
医学1区
文献类型:
--
作者:
Causey, Corey P.;Jones, Justin E.;Slack, Jessica L.;Kamei, Daisuke;Jones, Larry E., Jr.;Subramanian, Venkataraman;Knuckley, Bryan;Ebrahimi, Pedram;Chumanevich, Alexander A.;Luo, Yuan;Hashimoto, Hiroshi;Sato, Mamoru;Hofseth, Lorne J.;Thompson, Paul R.

文献摘要

参考文献

被引文献

相似文献

蛋白质精氨酸脱亚胺酶(PAD)活性在许多人类疾病中上调,包括类风湿性关节炎、溃疡性结肠炎和癌症。这些酶,在人类中有五种(PADs 1-4和6)调节基因转录,细胞分化和先天免疫反应。在我们成功产生的F-和Cl-脒(其不可逆地抑制所有PAD)的基础上,进行了结构活性关系,以开发具有改善的效力和选择性的第二代化合物。在骨架酰胺的邻位引入羧酸酯导致鉴定出N-α-(2-羧基)苯甲酰基-N5-(2-氟-1-亚氨基乙基)-L-鸟氨酸酰胺(o-F-脒)和Nα-(2-羧基)苯甲酰基-N5-(2-氯-1-亚氨基乙基)-L-鸟氨酸酰胺(o-Cl-脒)作为PAD灭活剂,具有改善的效力(高达65倍)和选择性(高达25倍)。相对于F-和Cl-脒,该化合物在纤维素中也显示出增强的效力。因此,这些化合物将是PAD功能的通用化学探针。
Protein Arginine Deiminase (PAD) activity is upregulated in a number of human diseases, including rheumatoid arthritis, ulcerative colitis, and cancer. These enzymes, there are five in humans (PADs 1-4 and 6) regulate gene transcription, cellular differentiation, and the innate immune response. Building on our successful generation F- and Cl-amidine, which irreversibly inhibit all of the PADs, a structure activity relationship was performed to develop second generation compounds with improved potency and selectivity. Incorporation of a carboxylate ortho to the backbone amide resulted in the identification of N-α-(2-carboxyl)benzoyl-N5-(2-fluoro-1-iminoethyl)-L-ornithine amide (o-F-amidine) and Nα-(2-carboxyl)benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide (o-Cl-amidine), as PAD inactivators with improved potency (up to 65-fold) and selectivity (up to 25-fold). Relative to F- and Cl-amidine, the compounds also show enhanced potency in cellulo. As such, these compounds will be versatile chemical probes of PAD function.
DOI: 10.1084/jem.20100239
发表时间: 2010-08-30
期刊: The Journal of experimental medicine
影响因子: --
作者:
Li P;Li M;Lindberg MR;Kennett MJ;Xiong N;Wang Y
通讯作者: Wang Y
DOI: 10.1107/s0907444904019158
发表时间: 2004-12-01
影响因子: 2.2
作者:
Emsley, P;Cowtan, K
通讯作者: Cowtan, K
DOI: 10.1128/mcb.01747-07
发表时间: 2008-08-01
影响因子: 5.3
作者:
Li, Pingxin;Yao, Hongjie;Wang, Yanming
通讯作者: Wang, Yanming
DOI: 10.1007/s10495-006-3715-4
发表时间: 2006-02-01
期刊: APOPTOSIS
影响因子: 7.2
作者:
Liu, GY;Liao, YF;Hung, HC
通讯作者: Hung, HC
DOI: 10.1021/bi100363t
发表时间: 2010-06-15
期刊: BIOCHEMISTRY
影响因子: 2.9
作者:
Knuckley, Bryan;Causey, Corey P.;Jones, Justin E.;Bhatia, Monica;Dreyton, Christina J.;Osborne, Tanesha C.;Takahara, Hidenari;Thompson, Paul R.
通讯作者: Thompson, Paul R.